Results 291 to 300 of about 136,697 (349)

Context, mechanisms and outcomes of a social enterprise model of residential rehabilitation for problem substance use: A realist‐informed process evaluation

Addiction, EarlyView.
Abstract Background and aims This study evaluated a three‐year residential rehabilitation programme, which aimed to support recovery from problem substance use via peer support and social enterprise activities. The aims were to clarify programme mechanisms and identify contextual factors associated with variation in outcomes.
Martin Anderson, Lucy Pickering, Mark McCann   +2 more
wiley   +1 more source

Buprenorphine Treatment for Opioid Use Disorder in Non-Addiction Specialty Settings.

JAMA Netw Open
Huebler S, Jones AL, Zhao H, Nelson RE, Hagedorn HJ, Hawkins EJ, Gordon AJ.   +6 more
europepmc   +1 more source

Management of Patients With Opioid Use Disorder (OUD). [PDF]

Cureus
Martin-Orr N, Yun S.
europepmc   +1 more source

Monitoring outcomes of substance use disorder among healthcare professionals in Utah: A retrospective study of the professionals health program

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Substance use disorders (SUD) among healthcare professionals threaten both patient safety and workforce stability. Professional health programs (PHPs) aim to support recovery and safe practice reentry, yet outcomes for non‐physician professionals remain underexplored. This study assessed return to use and professional
Mubo O. Olufemi, Lisa J. Merlo, Melissa Cheng, Hongwei Zhao, Justin Yang, Matthew S. Thiese   +5 more
wiley   +1 more source

Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Patients using fentanyl have worse treatment outcomes; however, little is known about other drugs that complicate treatment. Methods A national survey (n = 396) was conducted using a random sample of clinicians waivered to prescribe buprenorphine in the United States.
Erin L. Winstanley, Jane M. Liebschutz, Cristina Murray‐Krezan, Galen E. Switzer, Samantha Nash, Sarah Kawasaki   +5 more
wiley   +1 more source

Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data. [PDF]

Pharmacoepidemiol Drug Saf
Ross RK, Butler AM, Seamans MJ, Williams AR, Samples H, Rudolph KE.   +5 more
europepmc   +1 more source

Improving access to direct acting antivirals via a multimodal integrated care program in an addiction medicine clinic

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Injection drug use is a driver of hepatitis C virus (HCV) transmission, thus integrating HCV care into addiction care is likely necessary for HCV elimination. Here we describe how we integrated HCV care into our addiction medicine (AM) clinic and evaluate its effect on HCV treatment.
Arya Zandvakili, Joseph Rattenni, James Burton, Lakshmi Guduguntla, Marcus Osman, Sayeh Sabbagh, Stephan Arndt, Ben Miskle, Quanhathai Kaewpoowat, Michael Ohl, Andrea Weber, Alison Lynch   +11 more
wiley   +1 more source

Trends in Prenatal Opioid Use Disorder in California, 2010-2022. [PDF]

Am J Prev Med
Goldman-Mellor S, Pathak J, Margerison CE.   +2 more
europepmc   +1 more source

Understanding barriers and facilitators to women's recovery from opioid use disorder: A focus group study. [PDF]

J Soc Work Pract Addict
Ward MK, Mommaerts K, Jafry A, Greenamyre E, Hughson W, Landry R, Sasser C, Soria M, Mortensen E, Wagner EF.   +9 more
europepmc   +1 more source